Compare LTGO & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LTGO | DMLP |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2026 | 2002 |
| Metric | LTGO | DMLP |
|---|---|---|
| Price | $20.22 | $27.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 661.1K | 271.2K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | ★ 9.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $152,832,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.22 | $20.85 |
| 52 Week High | $20.50 | $28.95 |
| Indicator | LTGO | DMLP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 59.95 |
| Support Level | N/A | $27.41 |
| Resistance Level | N/A | $28.13 |
| Average True Range (ATR) | 0.00 | 0.62 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 0.00 | 84.83 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.